Functional imaging for radiation treatment planning, response assessment, and adaptive therapy in head and neck cancer.
暂无分享,去创建一个
Priya Bhatnagar | Robin Prestwich | A. Scarsbrook | M. Subesinghe | C. Patel | Andrew F Scarsbrook | Chirag Patel | Manil Subesinghe | R. Prestwich | P. Bhatnagar
[1] G. Stoffels,et al. 18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[2] G. Antoni,et al. 18F-ML-10, a PET Tracer for Apoptosis: First Human Study , 2011, The Journal of Nuclear Medicine.
[3] A. Riegel,et al. Variability of gross tumor volume delineation in head-and-neck cancer using CT and PET/CT fusion. , 2005, International journal of radiation oncology, biology, physics.
[4] Xavier Geets,et al. Assessment by a deformable registration method of the volumetric and positional changes of target volumes and organs at risk in pharyngo-laryngeal tumors treated with concomitant chemo-radiation. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[5] B. Campbell,et al. Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma. , 2008, International journal of radiation oncology, biology, physics.
[6] Daniela Thorwarth,et al. Hypoxia dose painting by numbers: a planning study. , 2007, International journal of radiation oncology, biology, physics.
[7] G. Watkins,et al. Kinetic Analysis of 3′-Deoxy-3′-18F-Fluorothymidine (18F-FLT) in Head and Neck Cancer Patients Before and Early After Initiation of Chemoradiation Therapy , 2009, Journal of Nuclear Medicine.
[8] Z. Rumboldt,et al. Whole-Tumor Perfusion CT Parameters and Glucose Metabolism Measurements in Head and Neck Squamous Cell Carcinomas: A Pilot Study Using Combined Positron-Emission Tomography/CT Imaging , 2008, American Journal of Neuroradiology.
[9] R. Hoffman,et al. Altered methionine metabolism, DNA methylation and oncogene expression in carcinogenesis. A review and synthesis. , 1984, Biochimica et biophysica acta.
[10] H. Minn,et al. Evaluation of early response to radiotherapy in head and neck cancer measured with [11C]methionine-positron emission tomography. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[11] T. Higuchi,et al. Positron emission tomographic imaging with 11C-choline in differential diagnosis of head and neck tumors: comparison with 18F-FDG PET , 2004 .
[12] W. Cai,et al. Non-Invasive PET Imaging of EGFR Degradation Induced by a Heat Shock Protein 90 Inhibitor , 2008, Molecular Imaging and Biology.
[13] S. Kannan,et al. Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[14] Jens Overgaard,et al. Hypoxic radiosensitization: adored and ignored. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] Fréderic Duprez,et al. Adaptive dose painting by numbers for head-and-neck cancer. , 2011, International journal of radiation oncology, biology, physics.
[16] H. Matsuda,et al. 18F-FDG versus 11C-choline PET/CT for the imaging of advanced head and neck cancer after combined intra-arterial chemotherapy and radiotherapy: the time period during which PET/CT can reliably detect non-recurrence , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[17] Sandra Nuyts,et al. Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. , 2007, International journal of radiation oncology, biology, physics.
[18] S Mutic,et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. , 2001, International journal of radiation oncology, biology, physics.
[19] W. Oyen,et al. 18F-FLT PET Does Not Discriminate Between Reactive and Metastatic Lymph Nodes in Primary Head and Neck Cancer Patients , 2007, Journal of Nuclear Medicine.
[20] F. Howe,et al. Tumor R2* is a prognostic indicator of acute radiotherapeutic response in rodent tumors , 2004, Journal of magnetic resonance imaging : JMRI.
[21] J. Bussink,et al. Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer. , 2008, The Lancet. Oncology.
[22] N. Lee,et al. Target volume delineation in oropharyngeal cancer: impact of PET, MRI, and physical examination. , 2010, International journal of radiation oncology, biology, physics.
[23] H. Minn,et al. Blood metabolism of [methyl-11C]choline; implications for in vivo imaging with positron emission tomography , 2000, European Journal of Nuclear Medicine.
[24] Fréderic Duprez,et al. Maximum tolerated dose in a phase I trial on adaptive dose painting by numbers for head and neck cancer. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[25] B. Sanghera,et al. Adaptive 18fluoro-2-deoxyglucose positron emission tomography/computed tomography-based target volume delineation in radiotherapy planning of head and neck cancer. , 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).
[26] J. Talbot,et al. Prospective Comparison of FDG and FET PET/CT in Patients with Head and Neck Squamous Cell Carcinoma , 2008, Molecular Imaging and Biology.
[27] Jason S. Lewis,et al. Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia. , 2007, Dalton transactions.
[28] John C Gore,et al. Molecular Imaging of Therapeutic Response to Epidermal Growth Factor Receptor Blockade in Colorectal Cancer , 2008, Clinical Cancer Research.
[29] R. Boellaard,et al. Reproducibility of quantitative 18F-3′-deoxy-3′-fluorothymidine measurements using positron emission tomography , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[30] Tohru Shiga,et al. Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas. , 2002, International journal of radiation oncology, biology, physics.
[31] A. Buck,et al. 18F-FET PET/CT in Advanced Head and Neck Squamous Cell Carcinoma: an Intra-individual Comparison with 18F-FDG PET/CT , 2011, Molecular Imaging and Biology.
[32] G. Weinstein,et al. Diffusion-Weighted Magnetic Resonance Imaging for Predicting and Detecting Early Response to Chemoradiation Therapy of Squamous Cell Carcinomas of the Head and Neck , 2009, Clinical Cancer Research.
[33] A. Drzezga,et al. First Clinical Experience with Integrated Whole-Body PET/MR: Comparison to PET/CT in Patients with Oncologic Diagnoses , 2012, The Journal of Nuclear Medicine.
[34] F. Howe,et al. The response to carbogen breathing in experimental tumour models monitored by gradient-recalled echo magnetic resonance imaging. , 1997, British Journal of Cancer.
[35] M Schwaiger,et al. Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[36] D. Yeung,et al. Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging. , 2007, Radiology.
[37] R. Thomlinson,et al. Oxygen effect and reoxygenation in radiotherapy , 1973 .
[38] John L. Humm,et al. Pharmacokinetic Analysis of Hypoxia 18F-Fluoromisonidazole Dynamic PET in Head and Neck Cancer , 2010, Journal of Nuclear Medicine.
[39] B. Narasimhan,et al. In vivo 1H magnetic resonance spectroscopy of lactate in patients with stage IV head and neck squamous cell carcinoma. , 2008, International journal of radiation oncology, biology, physics.
[40] X Allen Li,et al. Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma. , 2006, International journal of radiation oncology, biology, physics.
[41] D. Mankoff,et al. Hypoxia imaging-directed radiation treatment planning , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[42] T S Koh,et al. Perfusion CT in Squamous Cell Carcinoma of the Upper Aerodigestive Tract: Long-Term Predictive Value of Baseline Perfusion CT Measurements , 2010, American Journal of Neuroradiology.
[43] S M Evans,et al. Quantification of longitudinal tissue pO2 gradients in window chamber tumours: impact on tumour hypoxia , 1999, British Journal of Cancer.
[44] B. Carey,et al. Functional imaging for head and neck cancer. , 2010, The Lancet. Oncology.
[45] Kevin Harrington,et al. An exploratory study into the role of dynamic contrast-enhanced magnetic resonance imaging or perfusion computed tomography for detection of intratumoral hypoxia in head-and-neck cancer. , 2009, International journal of radiation oncology, biology, physics.
[46] Georgy Shakirin,et al. Preliminary assessment of dynamic contrast-enhanced CT implementation in pretreatment FDG-PET/CT for outcome prediction in head and neck tumors , 2010, Acta radiologica.
[47] R. Gupta,et al. An exploratory study into the role of dynamic contrast-enhanced (DCE) MRI metrics as predictors of response in head and neck cancers. , 2012, Clinical radiology.
[48] Sadek Nehmeh,et al. The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography. , 2008, International journal of radiation oncology, biology, physics.
[49] D. Buckley,et al. Perfusion estimated with rapid dynamic contrast-enhanced magnetic resonance imaging correlates inversely with vascular endothelial growth factor expression and pimonidazole staining in head-and-neck cancer: a pilot study. , 2011, International journal of radiation oncology, biology, physics.
[50] W. Weber. Monitoring Tumor Response to Therapy with 18F-FLT PET , 2010, Journal of Nuclear Medicine.
[51] U Ruotsalainen,et al. Carbon-11-methionine and PET is an effective method to image head and neck cancer. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[52] Martin Westhofen,et al. FDG—a marker of tumour hypoxia? A comparison with [18F]fluoromisonidazole and pO2-polarography in metastatic head and neck cancer , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[53] Sigrid Stroobants,et al. Dose Painting in Radiotherapy for Head and Neck Squamous Cell Carcinoma: Value of Repeated Functional Imaging with 18F-FDG PET, 18F-Fluoromisonidazole PET, Diffusion-Weighted MRI, and Dynamic Contrast-Enhanced MRI , 2009, Journal of Nuclear Medicine.
[54] Benoît Macq,et al. Comparison of 12 deformable registration strategies in adaptive radiation therapy for the treatment of head and neck tumors. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[55] Jean-François Daisne,et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. , 2004, Radiology.
[56] Alicia Y Toledano,et al. An evaluation of the variability of tumor-shape definition derived by experienced observers from CT images of supraglottic carcinomas (ACRIN protocol 6658). , 2007, International journal of radiation oncology, biology, physics.
[57] J R Griffiths,et al. BOLD MRI of human tumor oxygenation during carbogen breathing , 2001, Journal of magnetic resonance imaging : JMRI.
[58] R. Ewers,et al. Uptake of 18F-FLT and 18F-FDG in primary head and neck cancer correlates with survival , 2008, Nuklearmedizin.
[59] R. Hermans,et al. Applications of diffusion-weighted magnetic resonance imaging in head and neck squamous cell carcinoma , 2010, Neuroradiology.
[60] Matthias Reimold,et al. Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[61] Anne Bol,et al. A gradient-based method for segmenting FDG-PET images: methodology and validation , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[62] Brian O'Sullivan,et al. Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[63] U Ruotsalainen,et al. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine in head and neck cancer. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[64] W. Oyen,et al. 18F-FLT PET/CT for Early Response Monitoring and Dose Escalation in Oropharyngeal Tumors , 2010, Journal of Nuclear Medicine.
[65] H. Minn,et al. Pharmacokinetics of [18F]FETNIM: A Potential Hypoxia Marker for PET , 2001 .
[66] Ruth C Carlos,et al. Computed Tomography Perfusion of Squamous Cell Carcinoma of the Upper Aerodigestive Tract: Initial Results , 2003, Journal of computer assisted tomography.
[67] K. Miles,et al. Molecular imaging with dynamic contrast-enhanced computed tomography. , 2010, Clinical radiology.
[68] Wade P. Smith,et al. Hypoxia imaging with [F-18] FMISO-PET in head and neck cancer: potential for guiding intensity modulated radiation therapy in overcoming hypoxia-induced treatment resistance. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[69] J. Brunt. Computed tomography-magnetic resonance image registration in radiotherapy treatment planning. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).
[70] Aswin L Hoffmann,et al. Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer. , 2007, International journal of radiation oncology, biology, physics.
[71] Srinivasan Vijayakumar,et al. Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer. , 2011, International journal of radiation oncology, biology, physics.
[72] Tomio Inoue,et al. Assessment of tumor hypoxia by 62Cu-ATSM PET/CT as a predictor of response in head and neck cancer: a pilot study , 2011, Annals of nuclear medicine.
[73] I. Ziv,et al. Apoptosis imaging with PET-18F-ML-10 for early assessment of response of brain metastases to radiotherapy , 2009 .
[74] H. Minn,et al. Pharmacokinetics of [18F]FETNIM: a potential marker for PET. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[75] B. Panizza,et al. Results of a prospective study of positron emission tomography–directed management of residual nodal abnormalities in node‐positive head and neck cancer after definitive radiotherapy with or without systemic therapy , 2011, Head & neck.
[76] F. Hoebers,et al. 99mTc Hynic-rh-Annexin V scintigraphy for in vivo imaging of apoptosis in patients with head and neck cancer treated with chemoradiotherapy , 2007, European Journal of Nuclear Medicine and Molecular Imaging.
[77] K. Någren,et al. Evaluation of response to radiotherapy in head and neck cancer by positron emission tomography and [11C]methionine. , 1995, International journal of radiation oncology, biology, physics.
[78] E. Hall,et al. Radiobiology for the radiologist , 1973 .
[79] R. Fisher,et al. Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[80] B. Seifert,et al. PET/CT Staging Followed by Intensity-Modulated Radiotherapy (IMRT) Improves Treatment Outcome of Locally Advanced Pharyngeal Carcinoma: a matched-pair comparison , 2007, Radiation oncology.
[81] F. Gallagher. An introduction to functional and molecular imaging with MRI. , 2010, Clinical radiology.
[82] M. Castillo,et al. The choline/creatine ratio in five benign neoplasms: comparison with squamous cell carcinoma by use of in vitro MR spectroscopy. , 2000, AJNR. American journal of neuroradiology.
[83] Bernd J. Pichler,et al. Feasibility of simultaneous PET/MR imaging in the head and upper neck area , 2011, European Radiology.
[84] Anne Bol,et al. Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[85] L. Bastholt,et al. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[86] Sylvain Moreau,et al. Early response to chemotherapy in hypopharyngeal cancer: assessment with (11)C-methionine PET, correlation with morphologic response, and clinical outcome. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[87] H. Taubert,et al. Optimising the therapeutic ratio in head and neck cancer. , 2010, The Lancet. Oncology.
[88] Daniela Thorwarth,et al. Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[89] Sandra Nuyts,et al. Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging. , 2009, Radiology.
[90] C. Njeh,et al. Tumor delineation: The weakest link in the search for accuracy in radiotherapy , 2008, Journal of medical physics.
[91] Morand Piert,et al. Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[92] Xavier Geets,et al. Adaptive biological image-guided IMRT with anatomic and functional imaging in pharyngo-laryngeal tumors: impact on target volume delineation and dose distribution using helical tomotherapy. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[93] C. McConkey,et al. A systematic review and meta‐analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy , 2008, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.
[94] M. Alber,et al. Imaging oxygenation of human tumours , 2006, European Radiology.
[95] K. Muller,et al. Proton MR spectroscopy of squamous cell carcinoma of the extracranial head and neck: in vitro and in vivo studies. , 1997, AJNR. American journal of neuroradiology.
[96] L. Wiens,et al. Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[97] S. Mukherji,et al. Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy? , 2007, AJNR. American journal of neuroradiology.
[98] Jonathan G. Li,et al. Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer. , 2008, International journal of radiation oncology, biology, physics.
[99] D. Brizel,et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[100] T. Cotter,et al. Apoptosis and cancer: the genesis of a research field , 2009, Nature Reviews Cancer.
[101] Sadek Nehmeh,et al. Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study. , 2008, International journal of radiation oncology, biology, physics.
[102] Gig Mageras,et al. Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer. , 2008, International journal of radiation oncology, biology, physics.
[103] Cornelis A T van den Berg,et al. Validation of imaging with pathology in laryngeal cancer: accuracy of the registration methodology. , 2011, International journal of radiation oncology, biology, physics.
[104] R. Beets-Tan,et al. Diagnostic accuracy and additional value of diffusion-weighted imaging for discrimination of malignant cervical lymph nodes in head and neck squamous cell carcinoma , 2009, Neuroradiology.
[105] Johan Bussink,et al. PET-CT for response assessment and treatment adaptation in head and neck cancer. , 2010, The Lancet. Oncology.